China Sxt Pharmaceuticals Inc (SXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,205 | -3,304 | -3,099 | -5,935 | -5,736 |
| Depreciation Amortization | 74 | 82 | 203 | 250 | 320 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 328 |
| Accounts receivable | 291 | -257 | -321 | 913 | 832 |
| Accounts payable and accrued liabilities | -694 | -114 | -29 | 10 | -23 |
| Other Working Capital | -2,390 | -972 | -382 | 1,416 | 1,903 |
| Other Operating Activity | 4,907 | 2,219 | 1,700 | 3,266 | 2,645 |
| Operating Cash Flow | $-4,018 | $-2,345 | $-1,928 | $-81 | $268 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 64 | -7 | -71 | -63 |
| Other Investing Activity | -1,251 | 0 | 34 | 58 | 16 |
| Investing Cash Flow | $-1,251 | $64 | $26 | $-12 | $-47 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 521 | 1,853 | -708 | 4,031 | 2,805 |
| Debt Repayment | -377 | -1,918 | -79 | -26 | -33 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 3,115 |
| Other Financing Activity | 14,289 | 8,464 | -1,838 | -1,063 | -4,292 |
| Financing Cash Flow | $14,434 | $8,399 | $-2,624 | $2,942 | $1,595 |
| Exchange Rate Effect | 882 | -65 | -765 | -1,050 | 394 |
| Beginning Cash Position | 18,129 | 12,077 | 17,369 | 15,570 | 13,359 |
| End Cash Position | 28,176 | 18,129 | 12,077 | 17,369 | 15,570 |
| Net Cash Flow | $10,047 | $6,052 | $-5,291 | $1,799 | $2,211 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,018 | -2,345 | -1,928 | -81 | 268 |
| Capital Expenditure | N/A | -2 | -7 | -71 | -63 |
| Free Cash Flow | -4,018 | -2,347 | -1,935 | -152 | 206 |